PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.

Gao, Jiafeng

PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. [electronic resource] - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Dec 2019 - 105070 p. digital

Publication Type: Journal Article

1879-0720

10.1016/j.ejps.2019.105070 doi


Animals
Antineoplastic Agents--administration & dosage
Biological Transport
Breast Neoplasms--drug therapy
Cell Line, Tumor
Cell Survival--drug effects
Curcumin--administration & dosage
Dogs
Drug Compounding--methods
Drug Liberation
Drug Therapy, Combination--methods
Female
Humans
Lipid Bilayers--chemistry
Lysosomes--metabolism
Mice, Inbred BALB C
Mice, Nude
Mitochondria--metabolism
Nanocapsules--chemistry
Paclitaxel--administration & dosage
Polyethylene Glycols--chemistry
Porosity
Rats, Sprague-Dawley
Silicon Dioxide--chemistry
Surface Properties
Tumor Burden--drug effects